SpaceX loses $1T as ASML raises gross margin to 55%

SpaceX's Market Value Plunges

SpaceX's stock dropped 40% from its peak, wiping out over $1 trillion in market value and falling below its $135 IPO price to $132.75 on July 15th. Ed Elson noted this follows a pre-IPO Morningstar valuation of just $62 per share.

This signals a major correction in the valuation of high-growth, often speculative, private tech companies. Practitioners should reassess risk premiums and growth projections for similar ventures, recognizing that even market darlings are not immune to significant recalibration. > Watch: Private tech valuations, next major IPO pricing.

Netflix Slows Growth, YouTube Holds Steady

Netflix reported its second consecutive quarter of slowing sales growth and provided lower third-quarter revenue guidance. Geeta Ranganathan noted Netflix's share of TV viewing time is declining while YouTube's remains constant, with no increase in operating margin guidance.

Established digital content platforms face persistent competition and saturation, forcing a re-evaluation of growth strategies beyond subscriber additions. The shift towards platforms like YouTube indicates sustained pressure on traditional streaming models. > Watch: Netflix subscriber growth vs. YouTube engagement.

ASML Boosts Margin, Sales Forecasts

Semiconductor equipment manufacturer ASML raised its full-year gross margin expectation to 55% and lifted its annual sales forecast for the second time this year. Tammy Chu highlighted the gross margin revision from a midpoint of 52%.

Strong demand and pricing power persist for foundational chip manufacturing equipment, indicating a robust underlying investment cycle in core digital infrastructure. This suggests resilience in the supply chain for critical hardware, even amidst broader market volatility. > Watch: ASML order book and next quarter's margin.

Apple Integrates Alibaba LLM in China

Apple will integrate Alibaba's Qwen large language model into its Apple Intelligence services for the Chinese market. Ed Elson stated this strategic partnership is key to deploying new AI features within China's regulatory environment.

Navigating complex geopolitical and regulatory landscapes requires pragmatic, localized AI partnerships rather than a one-size-fits-all global deployment. This prioritizes market access and compliance over proprietary technological purity. > Watch: Apple Intelligence deployment in other regulated markets.

New LLM Entrant: Inkling by Thinking Machines Lab

Thinking Machines Lab released Inkling, a 975 billion parameter Mixture of Experts (MoE) model with 41 billion active parameters. Nathaniel Whittemore positioned it as a significant new entrant in the competitive LLM space.

The LLM market continues to see rapid proliferation of large, competitive models, increasing pressure on existing players and driving further commoditization of foundational model capabilities. This intensifies the race for differentiation in application and efficiency. > Watch: Inkling's adoption metrics and specific use cases.

Proton Shares Payment Data with Authorities

A 404 Media report claims Proton provided payment data for the 'StopCopCity' account to Swiss authorities, who then shared it with the FBI. Bart Butler's statements about complying only with Swiss legal orders contrast with this action.

Companies promoting strong privacy assurances face increasing pressure from law enforcement, highlighting the practical limits of digital privacy guarantees. This creates a trust deficit for users relying on such services for anonymity. > Watch: Proton's official response to the 404 Media report.

Eli Lilly Acquires Atai Beckley for Mental Health

Pharmaceutical giant Eli Lilly entered an agreement to acquire Atai Beckley for up to $3.8 billion. Tim Stenebek noted this signals a major investment in developing therapies for mental health conditions.

Significant capital is flowing into non-AI biotech and pharmaceutical innovation, particularly in areas like mental health. This demonstrates a diversification of strategic investment beyond the immediate AI hype cycle into other high-impact scientific fields. > Watch: Next major biotech M&A in mental health.